What Strata Critical Medical, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 1 | 3 |
| Sells | 0 | 6 |
| Total trades | 14 | 68 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 68 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Lauck Andrew | Director | Nov 05 | Open-market buy · P | +2,000 | $5.00 | +$10K | 172,902 |
| Wunsch Scott M | CEO, Logistics | Oct 28 | Withheld — tax / exercise cost · F | −44,996 | $4.76 | −$214K | 746,254 |
| Wunsch Scott M | CEO, Logistics | Oct 28 | Grant / award · A | +1,416 | — | — | 791,250 |
| Wunsch Scott M | CEO, Logistics | Oct 28 | Grant / award · A | +57,173 | — | — | 789,834 |
| Wunsch Scott M | CEO, Logistics | Oct 28 | Grant / award · A | +57,173 | — | — | 732,661 |
| Tomkiel Melissa M. | Co-CEO and General Counsel | Sep 24 | Withheld — tax / exercise cost · F | −90,797 | $5.27 | −$479K | 2,153,678 |
| Tomkiel Melissa M. | Co-CEO and General Counsel | Sep 24 | Grant / award · A | +177,858 | — | — | 2,244,475 |
| Heyburn William A. | Co-CEO and CFO | Sep 24 | Withheld — tax / exercise cost · F | −98,356 | $5.27 | −$518K | 1,757,850 |
| Heyburn William A. | Co-CEO and CFO | Sep 24 | Grant / award · A | +177,858 | — | — | 1,856,206 |
| Tomkiel Melissa M. | Co-CEO and General Counsel | Sep 08 | Withheld — tax / exercise cost · F | −29,730 | $5.31 | −$158K | 2,066,617 |
| Heyburn William A. | Co-CEO and CFO | Sep 08 | Withheld — tax / exercise cost · F | −31,671 | $5.31 | −$168K | 1,678,348 |
| Verdetto Louis R. | CEO, Clinical Services | Sep 08 | Withheld — tax / exercise cost · F | −5,697 | $5.31 | −$30.3K | 1,128,096 |
| Cohen Amir | Chief Accounting Officer | Sep 08 | Withheld — tax / exercise cost · F | −4,645 | $5.31 | −$24.7K | 177,154 |
| Wunsch Scott M | CEO, Logistics | Sep 08 | Withheld — tax / exercise cost · F | −5,711 | $5.31 | −$30.3K | 663,043 |
| Love Reginald | Director | Aug 10 | Open-market sale · S | −5,091 | $5.75 | −$29.3K | 146,481 |
| Heyburn William A. | Co-CEO and CFO | Jul 31 | Withheld — tax / exercise cost · F | −199,209 | $5.09 | −$1.01M | 1,710,019 |
| Cohen Amir | Chief Accounting Officer | Jul 31 | Withheld — tax / exercise cost · F | −34,015 | $5.09 | −$173K | 181,799 |
| Tomkiel Melissa M. | Co-CEO and General Counsel | Jul 31 | Withheld — tax / exercise cost · F | −212,309 | $5.09 | −$1.08M | 2,096,347 |
| Wunsch Scott M | CEO, Logistics | Jul 31 | Withheld — tax / exercise cost · F | −13,992 | $5.09 | −$71.2K | 668,754 |
| Wunsch Scott M | CEO, Logistics | Jul 30 | Grant / award · A | +2,658 | — | — | 675,488 |
Loading...